Table 2 Perception of GPs regarding their role in the care of RA patients
n (%) | |||||
|---|---|---|---|---|---|
Not at all important | Unimportant | Relatively important | Very important | Extremely important | |
Disease diagnosis | 1 (0.4%) | 7 (2.8%) | 60 (24.3%) | 136 (55.1%) | 43 (17.4%) |
Disease monitoring | 3 (1.2%) | 67 (27.1%) | 113 (45.7%) | 57 (23.1%) | 7 (2.8%) |
Treatment effectiveness monitoring | 5 (2.0%) | 75 (30.4%) | 105 (42.5%) | 54 (21.9%) | 8 (3.2%) |
Treatment tolerance monitoring | 2 (0.8%) | 18 (7.3%) | 118 (47.8%) | 87 (35.2%) | 22 (8.9%) |
Prescription refills of DMARDs | 23 (9.3%) | 84 (34.0%) | 86 (34.8%) | 45 (18.2%) | 9 (3.6%) |
Therapeutic adjustments (corticosteroids or DMARDs) | 24 (9.7%) | 111 (44.9%) | 78 (31.6%) | 32 (13.0%) | 2 (0.8%) |
Management of co-morbidities | 1 (0.4%) | 11 (4.5%) | 69 (27.9%) | 122 (49.4%) | 44 (17.8%) |
Supporting patients in the treatment management | 2 (0.8%) | 38 (15.4%) | 92 (37.2%) | 93 (37.7%) | 22 (8.2%) |